Aquestive Therapeutics Inc (AQST)
4.56
+0.05
(+1.11%)
USD |
NASDAQ |
Nov 22, 10:29
Aquestive Therapeutics Revenue (Quarterly): 13.54M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 13.54M |
June 30, 2024 | 20.10M |
March 31, 2024 | 12.05M |
December 31, 2023 | 13.21M |
September 30, 2023 | 13.00M |
June 30, 2023 | 13.24M |
March 31, 2023 | 11.13M |
December 31, 2022 | 10.68M |
September 30, 2022 | 11.46M |
June 30, 2022 | 13.26M |
March 31, 2022 | 12.27M |
December 31, 2021 | 11.08M |
September 30, 2021 | 13.29M |
June 30, 2021 | 15.34M |
March 31, 2021 | 11.12M |
December 31, 2020 | 7.149M |
Date | Value |
---|---|
September 30, 2020 | 8.26M |
June 30, 2020 | 21.68M |
March 31, 2020 | 8.765M |
December 31, 2019 | 16.42M |
September 30, 2019 | 12.42M |
June 30, 2019 | 11.13M |
March 31, 2019 | 12.64M |
December 31, 2018 | 16.82M |
September 30, 2018 | 13.27M |
June 30, 2018 | 13.93M |
March 31, 2018 | 23.41M |
December 31, 2017 | 12.20M |
September 30, 2017 | 27.15M |
June 30, 2017 | 11.14M |
March 31, 2017 | 16.44M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
7.149M
Minimum
Dec 2020
21.68M
Maximum
Jun 2020
12.85M
Average
12.64M
Median
Revenue (Quarterly) Benchmarks
Rockwell Medical Inc | 28.32M |
Cormedix Inc | 11.46M |
Axogen Inc | 48.64M |
NovaBay Pharmaceuticals Inc | 2.441M |
Palatin Technologies Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -11.51M |
Total Expenses (Quarterly) | 21.83M |
EPS Diluted (Quarterly) | -0.13 |
Enterprise Value | 364.60M |
Gross Profit Margin (Quarterly) | 67.24% |
Profit Margin (Quarterly) | -84.99% |
Earnings Yield | -10.18% |
Normalized Earnings Yield | -9.912 |